Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Operating Income: 2019-2025

Historic Operating Income for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $65.5 million.

  • Harmony Biosciences Holdings' Operating Income rose 6.12% to $65.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $225.6 million, marking a year-over-year increase of 28.72%. This contributed to the annual value of $190.8 million for FY2024, which is 0.63% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Operating Income stood at $65.5 million, which was up 35.92% from $48.2 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Operating Income registered a high of $65.5 million during Q3 2025, and its lowest value of $11.9 million during Q3 2022.
  • Over the past 3 years, Harmony Biosciences Holdings' median Operating Income value was $52.0 million (recorded in 2024), while the average stood at $50.3 million.
  • In the last 5 years, Harmony Biosciences Holdings' Operating Income skyrocketed by 442.05% in 2023 and then slumped by 54.47% in 2024.
  • Harmony Biosciences Holdings' Operating Income (Quarterly) stood at $28.6 million in 2021, then soared by 66.30% to $47.6 million in 2022, then decreased by 15.58% to $40.2 million in 2023, then soared by 38.64% to $55.7 million in 2024, then increased by 6.12% to $65.5 million in 2025.
  • Its Operating Income stands at $65.5 million for Q3 2025, versus $48.2 million for Q2 2025 and $56.2 million for Q1 2025.